-
Better Buy: AbbVie vs. Merck
Post on 5/26/20
-
Coty Share Value Climbs After European Launch of Kylie Skin
Post on 5/26/20
-
Intercept Pharmaceuticals Shares Fall 13% After FDA Delays an Advisory Committee Meeting
Post on 5/26/20
-
Regeneron Announces Secondary Offering of its Common Stock
Post on 5/25/20
-
ContraFect Corp. Prices $52.5M Public Offering of Common Stock and Warrants
Post on 5/25/20
-
Bellerophon Therapeutics Closes $43.7M Public Offering of Common Stock
Post on 5/25/20
-
ViralClear Closes $10.8M Equity Financing
Post on 5/25/20
-
Oyster Point Pharma Closes Public Offering of Common Stock
Post on 5/25/20
-
Blink Fitness Plans to Reopen Seven Clubs in Texas
Post on 5/24/20
-
Blink Fitness Plans to Reopen Jacksonville Florida Location
Post on 5/24/20
-
Bellerophon Therapeutics Announces Proposed Public Offering of Common Stock
Post on 5/21/20
-
Chembio Diagnostics Announces US Distribution Agreement
Post on 5/21/20
-
Castlight Health Teams Up with New York State Department of Health
Post on 5/21/20
-
Hoth Announces Proposed Public Offering of Common Stock
Post on 5/21/20
-
Suburban Propane Partners with Jersey Mike’s Subs and RWJ University Hospital
Post on 5/21/20
-
Better Buy: GlaxoSmithKline vs. Pfizer
Post on 5/21/20
-
Johnson & Johnson Plans to Stop Selling Talc-Based Baby Powder
Post on 5/21/20
-
Pfizer Participates in Funding for Biotech Startup Amplyx
Post on 5/21/20
-
GlaxoSmithKline, Pfizer, and Shionogi's HIV Prevention Candidate Outperforms Gilead's Truvada
Post on 5/20/20
-
Johnson & Johnson's Oncology Team Posts Promising Cancer Trial Results
Post on 5/20/20
-
Voltron Therapeutics Publishes Letter to Shareholders
Post on 5/19/20
-
Bureau Veritas Appoints Cleveland Clinic as Medical Advisor
Post on 5/18/20
-
Enzychem Lifesciences Appoints Dr. Cameron Wolfe to Lead Development of EC-18 as a COVID-19 Therapeutic Drug
Post on 5/18/20
-
Citius Closes $7.5M Registered Direct Offering
Post on 5/18/20
-
Quest Diagnostics Incorporated: A Leader In Diagnostic Information Services
Post on 5/18/20
